Dual Mechanisms for the Inhibition of E2F Binding to RB by Cyclin-Dependent Kinase-Mediated RB Phosphorylation
Erik S. Knudsen(Roswell Park Comprehensive Cancer Center), Jean Y. J. Wang(University of California San Diego)
Cited by 290
Related Papers
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
|Nature Communications|2015|1.1k
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
|Endocrine Related Cancer|2011|299
p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
|Science|2019|238
CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer
|Oncotarget|2014|211
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
|Journal of Clinical Investigation|2006|192